What is the appropriate dosage of polyethylene glycol 3350 for an adult with chronic constipation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 10, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

PEG 3350 Dosage for Chronic Constipation

For adults with chronic constipation, use polyethylene glycol 3350 at 17 grams once daily, mixed in 4-8 ounces of liquid. This is the FDA-approved dose and the most extensively studied regimen, demonstrating sustained efficacy for up to 6 months 1, 2.

Standard Dosing Protocol

The recommended dose is 17 grams (approximately one heaping tablespoon) of PEG 3350 powder dissolved in 4-8 ounces of water, juice, soda, coffee, or tea, taken once daily 2. This dosing is based on:

  • Strong recommendation from the 2023 AGA-ACG guidelines with moderate certainty of evidence 1
  • FDA approval at this specific dose 1, 2
  • Demonstrated efficacy in a 6-month randomized controlled trial of 304 patients showing significant increases in complete spontaneous bowel movements per week (mean difference 2.90) 1, 3

Expected Timeline

  • First bowel movement typically occurs within 2-4 days (48-96 hours) 2
  • Optimal results are usually achieved between 1-2 weeks of continuous use 2
  • Response is durable over 6 months without evidence of tachyphylaxis 1, 4

Alternative Dosing Considerations

While 17 grams once daily is standard, some European studies used PEG with electrolytes at 17.5 grams twice daily (total 35 grams/day) 1. However, the once-daily 17-gram dose without electrolytes is preferred because:

  • It's the FDA-approved formulation available over-the-counter in the United States 1
  • Better patient adherence with once-daily dosing
  • Equally effective with fewer gastrointestinal side effects at the lower dose 5

Treatment Algorithm

  1. Start with 17 grams once daily - this is your default dose
  2. Continue for at least 1-2 weeks to assess full therapeutic effect 2
  3. May use for up to 6 months based on clinical trial data, though FDA labeling indicates "up to 2 weeks" for occasional constipation 1, 2, 4
  4. Can combine with fiber supplementation for enhanced effect, particularly in patients with low dietary fiber intake 1

Important Clinical Caveats

Side effects to anticipate:

  • Abdominal distension, loose stools, flatulence, and nausea are common but generally mild to moderate 1
  • Diarrhea occurs more frequently in the first week, then decreases markedly 3
  • Taking more than the prescribed dose may cause severe diarrhea and fluid loss 2

When NOT to use:

  • Patients with symptoms of bowel obstruction (nausea, vomiting, abdominal pain or distention) 2
  • Known allergy to polyethylene glycol 2

Key advantage over other laxatives: PEG 3350 demonstrated superior or equivalent efficacy compared to prucalopride, tegaserod, lactulose, and ispaghula husk in head-to-head trials, with better tolerability profiles 1, 6, 7.

Long-term Management

After successful treatment (typically 1-2 weeks), the medication can be discontinued once several satisfactory bowel movements occur 2. However, long-term use up to 12 months has been proven safe with no clinically significant changes in electrolytes or other laboratory parameters, including in elderly patients 4. The 2023 guidelines explicitly state that response is durable over 6 months 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.